BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36918304)

  • 1. A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset.
    Beksac M; Akin HY; Cengiz Seval G; Yurdakul Mesutoglu P; Anliacik RG; Anliacik E; Gurman G; Karaagaoglu E; Dalva K
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):394-400.e1. PubMed ID: 36918304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.
    Shimoni A; Vago L; Bernardi M; Yerushalmi R; Peccatori J; Greco R; Shem-Tov N; Lo Russo A; Danylesko I; Apel A; Bonini C; Lupo Stanghellini MT; Nagler A; Ciceri F
    Am J Hematol; 2017 Oct; 92(10):1011-1019. PubMed ID: 28631269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion.
    Nowak I; Malinowski A; Tchórzewski H; Barcz E; Wilczyński JR; Banasik M; Gryboś M; Kurpisz M; Luszczek W; Majorczyk E; Wiśniewski A; Senitzer D; Sun JY; Kuśnierczyk P
    J Reprod Immunol; 2011 Jan; 88(1):32-7. PubMed ID: 21134695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.
    Wiśniewski A; Jankowska R; Passowicz-Muszyńska E; Wiśniewska E; Majorczyk E; Nowak I; Frydecka I; Kuśnierczyk P
    Hum Immunol; 2012 Sep; 73(9):927-31. PubMed ID: 22836042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
    Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
    Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis.
    Sun HS; Liu DX; Bai YY; Hu NW
    Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related macular degeneration is associated with the HLA-Cw*0701 Genotype and the natural killer cell receptor AA haplotype.
    Goverdhan SV; Khakoo SI; Gaston H; Chen X; Lotery AJ
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5077-82. PubMed ID: 18515573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
    Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity.
    Beksac M; Akin HY; Gencer-Oncul EB; Yousefzadeh M; Cengiz Seval G; Gulten E; Akdemir Kalkan I; Cinar G; Memikoglu O; Karaagaoglu E; Dalva K
    Immunogenetics; 2021 Dec; 73(6):449-458. PubMed ID: 34536086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.
    Alomar SY; Alkhuriji A; Trayhyrn P; Alhetheel A; Al-Jurayyan A; Mansour L
    Immunogenetics; 2017 Feb; 69(2):69-76. PubMed ID: 27631728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients.
    Zhao XY; Chang YJ; Xu LP; Zhang XH; Liu KY; Li D; Huang XJ
    Br J Cancer; 2014 Sep; 111(6):1080-8. PubMed ID: 25077441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand.
    Solomon SR; Aubrey MT; Zhang X; Jackson KC; Roark CL; Freed BM; Morris LE; Holland HK; Solh MM; Bashey A
    Transplant Cell Ther; 2022 Sep; 28(9):601.e1-601.e8. PubMed ID: 35788088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
    J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
    Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
    PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Killer Cell Immunoglobulin-Like Receptors and Their HLA-Ligands with Type 1 Diabetes Among South Indian Population.
    Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
    Immunol Invest; 2023 Apr; 52(3):270-285. PubMed ID: 36705596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
    Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
    Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.